The company also reported $16 million in revenue from Titan Spine, a surface technology implant business it acquired earlier this year. During the second quarter earnings call, as transcribed by Seeking Alpha, Geoffrey Martha, president of Medtronic, said that the spine results are the best the company has seen in a “long, long, long time.”
“It really is a direct result of the surgical synergy strategy, which has real staying power here and has meaningfully improved the intrinsic value of our spine franchises,” said Mr. Martha. “As you pointed out, it’s the capital equipment, the Mazor O-arm navigation, significant placements and sales and pull through of the spine implants. It’s created a great competitive differentiation and a really nice business model for us.”
He did not specify the number of Mazor placements, but said it was meaningfully more than the competition. “When you stack quarter-after-quarter-after-quarter of meaningfully more placements than the competition, our installed base has gotten pretty big, and we’ve got a lot of momentum here,” Mr. Martha said.
More articles on spine surgery:
8 spine surgeons discuss key patient considerations
Dr. Kern Singh performs 1st outpatient spine surgeries at new Rush facility
What 6 spine surgeons say are common financial mistakes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
